Grants and Contributions:
Title:
Development of a cancer treatment
Agreement Number:
854494
Agreement Value:
$266,924.17
Agreement Date:
Sep 28, 2015 - May 28, 2019
Description:
Vaccine development
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Welwyn, Quebec, CA H3Y 3G2
Reference Number:
172-2018-2019-Q4-854494
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
830484747
Recipient Type:
For-profit organization
Additional Information:
This agreement has been amended 2 time(s). The end date of this agreements has been modified by -153 days. The total amendment value is -55,000 dollars.
Amendment Date
Jun 5, 2019
Recipient's Legal Name:
Folia Biotech inc.
Federal Riding Name:
Notre-Dame-de-Grâce--Westmount
Federal Riding Number:
24053
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
325410
Amendments: